BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33151412)

  • 1. Clinicopathologic and molecular features of six cases of phosphaturic mesenchymal tumor.
    Sun L; Dehner C; Kenney J; McNulty SM; Zhu X; Pfeifer JD; Maluf HM; Chrisinger JSA
    Virchows Arch; 2021 Apr; 478(4):757-765. PubMed ID: 33151412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphaturic mesenchymal tumor without osteomalacia: additional confirmation of the "nonphosphaturic" variant, with emphasis on the roles of FGF23 chromogenic in situ hybridization and FN1-FGFR1 fluorescence in situ hybridization.
    Sent-Doux KN; Mackinnon C; Lee JC; Folpe AL; Habeeb O
    Hum Pathol; 2018 Oct; 80():94-98. PubMed ID: 29514106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, morphological and immunohistochemical analysis of 13 cases of phosphaturic mesenchymal tumor - A holistic diagnostic approach.
    Chatterjee D; Bardia A; Pal R; Saikia UN; Bhadada SK; Radotra BD
    Ann Diagn Pathol; 2021 Oct; 54():151783. PubMed ID: 34329884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Klotho Overexpression Is Frequently Associated With Upstream Rearrangements in Fusion-Negative Phosphaturic Mesenchymal Tumors of Bone and Sinonasal Tract.
    Lee JC; Hsieh TH; Kao YC; Tsai CF; Huang HY; Shih CY; Song HL; Oda Y; Chih-Hsueh Chen P; Pan CC; Sittampalam K; Petersson F; Konishi E; Chiu WY; Chen CF; Carpenter TO; Lu TP; Chang CD; Huang SC; Folpe AL
    Mod Pathol; 2023 Dec; 36(12):100336. PubMed ID: 37742927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 50-Year-Old Man Presenting with Multiple Bone Lesions and a Diagnosis of Phosphaturic Mesenchymal Tumor of the Femur.
    Ren D; Wei K; Ifegwu I
    Am J Case Rep; 2024 Feb; 25():e942810. PubMed ID: 38361352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spectrum.
    Agaimy A; Michal M; Chiosea S; Petersson F; Hadravsky L; Kristiansen G; Horch RE; Schmolders J; Hartmann A; Haller F; Michal M
    Am J Surg Pathol; 2017 Oct; 41(10):1371-1380. PubMed ID: 28614212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant.
    Yamada Y; Kinoshita I; Kenichi K; Yamamoto H; Iwasaki T; Otsuka H; Yoshimoto M; Ishihara S; Toda Y; Kuma Y; Setsu N; Koga Y; Honda Y; Inoue T; Yanai H; Yamashita K; Ito I; Takahashi M; Ohga S; Furue M; Nakashima Y; Oda Y
    Histopathology; 2018 Feb; 72(3):460-471. PubMed ID: 28858396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis.
    Wasserman JK; Purgina B; Lai CK; Gravel D; Mahaffey A; Bell D; Chiosea SI
    Head Neck Pathol; 2016 Sep; 10(3):279-85. PubMed ID: 26759148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent overexpression of klotho in fusion-negative phosphaturic mesenchymal tumors with tumorigenic implications.
    Lee CH; Su SY; Sittampalam K; Chen PC; Petersson F; Kao YC; Carpenter TO; Hsieh TH; Konishi E; Tsai JW; Billings SD; Folpe AL; Lee JC
    Mod Pathol; 2020 May; 33(5):858-870. PubMed ID: 31792355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors.
    Lee JC; Su SY; Changou CA; Yang RS; Tsai KS; Collins MT; Orwoll ES; Lin CY; Chen SH; Shih SR; Lee CH; Oda Y; Billings SD; Li CF; Nielsen GP; Konishi E; Petersson F; Carpenter TO; Sittampalam K; Huang HY; Folpe AL
    Mod Pathol; 2016 Nov; 29(11):1335-1346. PubMed ID: 27443518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour.
    Lee JC; Jeng YM; Su SY; Wu CT; Tsai KS; Lee CH; Lin CY; Carter JM; Huang JW; Chen SH; Shih SR; Mariño-Enríquez A; Chen CC; Folpe AL; Chang YL; Liang CW
    J Pathol; 2015 Mar; 235(4):539-45. PubMed ID: 25319834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).
    Houang M; Clarkson A; Sioson L; Elston MS; Clifton-Bligh RJ; Dray M; Ranchere-Vince D; Decouvelaere AV; de la Fouchardiere A; Gill AJ
    Hum Pathol; 2013 Dec; 44(12):2711-8. PubMed ID: 24060005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphaturic Mesenchymal Tumors in the Head and Neck Demonstrate a Broad Clinical and Morphologic Spectrum.
    Hulme KR; Mahar A; Campbell RG; Clifton-Bligh R; Gill AJ; Palme CE; Gupta R
    Head Neck Pathol; 2022 Sep; 16(3):902-912. PubMed ID: 35119617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?
    Ledford CK; Zelenski NA; Cardona DM; Brigman BE; Eward WC
    Clin Orthop Relat Res; 2013 Nov; 471(11):3618-25. PubMed ID: 23868423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-induced osteomalacia: An overview.
    Jadhav SS; Shah R; Patil V
    Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101834. PubMed ID: 37935612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia.
    Colazo JM; DeCorte JA; Gillaspie EA; Folpe AL; Dahir KM
    Bone Rep; 2021 Jun; 14():100744. PubMed ID: 33490314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytological findings of phosphaturic mesenchymal tumor: Report of a case with summary of prior published cases.
    Das O; Mohin M; Dey S; Kar A; Singhania P; Adhikari S; Chowdhury S; Chatterjee U
    Diagn Cytopathol; 2024 Feb; 52(2):E44-E47. PubMed ID: 37897246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From epistaxis to bone pain-report of two cases illustrating the clinicopathological spectrum of phosphaturic mesenchymal tumour with fibroblast growth factor receptor 1 immunohistochemical and cytogenetic analyses.
    Mok Y; Lee JC; Lum JH; Petersson F
    Histopathology; 2016 May; 68(6):925-30. PubMed ID: 26407099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphaturic mesenchymal tumor: A chondromyxoid fibroma-like type.
    Koga K; Iwasaki H; Nabeshima K
    J Dermatol; 2023 Nov; 50(11):1484-1487. PubMed ID: 37350024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia.
    Abate V; Vergatti A; De Filippo G; Damiano V; Menale C; D'Elia L; Rendina D
    J Clin Endocrinol Metab; 2024 Feb; 109(3):e1006-e1011. PubMed ID: 38006315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.